Analytical Evaluation (analytical + evaluation)

Distribution by Scientific Domains


Selected Abstracts


ANALYTICAL EVALUATION OF THE FEASIBILITY OF SHEAROGRAPHY

EXPERIMENTAL TECHNIQUES, Issue 1 2002
A.K. Maji
First page of article [source]


PP amplitude bias caused by interface scattering: are diffracted waves guilty?

GEOPHYSICAL PROSPECTING, Issue 2 2003
Nathalie Favretto-Cristini
ABSTRACT This paper is concerned with the problem of interpretation of anomalous seismic amplitudes, induced by the amplitude-scattering phenomenon. This phenomenon occurs in the vicinity of a crack distribution at the interface between elastic layers. The purpose of this work is to obtain a better understanding of the physics of this distinctive phenomenon, in order to interpret correctly the amplitudes of the reflected events. By analogy with studies in optics and in acoustics, we suggest that diffraction is widely involved in the amplitude-scattering phenomenon. Analytical evaluation of the amount of energy carried by the reflected and the diffracted waves shows that neglecting diffraction in numerical models leads to local underestimation of the amplitude of waves reflected at interfaces with gas-filled crack distribution. [source]


Analytical evaluation of the Voigt function using binomial coefficients and incomplete gamma functions

MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY, Issue 4 2008
B. A. Mamedov
ABSTRACT Using the binomial expansion theorem, the simple general analytical expressions are obtained for the Voigt function arising in various fields of physical research. As we will seen, the present formulation yields compact closed-form expressions which enable the ready analytical calculation of the Voigt function. The validity of this approximation is tested by other calculation methods. The series expansion relations established in this work are accurate enough in the whole range of parameters. The convergence rate of the series is estimated and discussed. Some examples of this methodology are presented. [source]


Abstracts: In vitro/in vivo and analytical evaluation of sunless tanning formulations containing different rheology modifiers

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 5 2010
O. V. Dueva-Koganov
pp. 73,83 In vitro data suggest that different in vivo performances are expected for two dihydroxyacetone (DHA)-containing formulations with similar concentrations of DHA and excipients but different commercially available rheology modifiers: one with a cationic polymer-based rheology modifier (blend) [dimethylacrylamide/ethyltrimonium chloride methacrylate copolymer (and) propylene glycol dicaprylate/dicaprate (and) PPG-1 trideceth-6 (and) C10-11 isoparaffin]; and the other with a polyacrylamide-based rheology modifier (blend) [polyacrylamide (and) C13-14 isoparaffin (and) laureth-7]. Both rheology modifiers (blends) contained comparable levels of polymers and were used at 3% w/w (as supplied). Differences in color development were illustrated in vitro with respect to the yellow/red and lightness/chroma parameters, which were confirmed in the followup in vivo studies. The test article with the cationic polymer-based rheology modifier produced a more natural sunless tan, comparable to a desirable sun-induced tan, for all panelists, one that was more uniform and lasted longer compared with the sunless tan generated by the test article with the polyacrylamide-based rheology modifier. A method for HPLC analysis of DHA in sunless tanning formulations was established and utilized to confirm concentrations of DHA in test articles. [source]


Design Of Clinical Pharmacology Trials

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, Issue 11 2001
Stephen B Duffull
SUMMARY 1. There are a variety of methods that could be used to increase the efficiency of the design of experiments. However, it is only recently that such methods have been considered in the design of clinical pharmacology trials. 2. Two such methods, termed data-dependent (e.g. simulation) and data-independent (e.g. analytical evaluation of the information in a particular design), are becoming increasingly used as efficient methods for designing clinical trials. These two design methods have tended to be viewed as competitive, although a complementary role in design is proposed here. 3. The impetus for the use of these two methods has been the need for a more fully integrated approach to the drug development process that specifically allows for sequential development (i.e. where the results of early phase studies influence later-phase studies). 4. The present article briefly presents the background and theory that underpins both the data-dependent and -independent methods with the use of illustrative examples from the literature. In addition, the potential advantages and disadvantages of each method are discussed. [source]